AltraBio is an R&D company expert in analysis and interpretation of biomedical data in both preclinical and clinical development. Particularly focused on OMICS and Flow/Mass cytometry technologies, the goal of AltraBio is to unlock the value captured in large scale datasets generated in life science experimental studies.
Founded by a team of highly skilled professionals with experience at the interface of biology, medicine, statistics and informatics, AltraBio is well positioned to understand the complex data problems encountered in the life science industry and to address them by creating state-of-the-art techniques and tools.
AltraBio team has extensive experience in statistical modeling, machine learning, data mining and software/database design, as well as educational and professional background in biomedical sciences and medicine. In addition to designing and implementing computational solutions, they have the knowledge and skills to interpret the results of quantitative analysis in the context of current biomedical knowledge.